- Report
- June 2025
- 200 Pages
Global
From €2472EUR$2,789USD£2,128GBP
- Report
- April 2025
- 200 Pages
Global
From €7045EUR$7,950USD£6,067GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1772EUR$2,000USD£1,526GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1772EUR$2,000USD£1,526GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1329EUR$1,500USD£1,145GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1108EUR$1,250USD£954GBP
- Clinical Trials
- April 2025
- 40 Pages
Global
From €1108EUR$1,250USD£954GBP
- Report
- December 2024
- 150 Pages
Global
From €3500EUR$3,950USD£3,014GBP
- Report
- June 2025
- 150 Pages
Global
From €2392EUR$2,699USD£2,060GBP
- Report
- June 2025
- 150 Pages
Global
From €2392EUR$2,699USD£2,060GBP
- Report
- July 2023
- 105 Pages
Global
From €5273EUR$5,950USD£4,541GBP
- Report
- September 2020
- 40 Pages
China
From €2127EUR$2,400USD£1,832GBP
- Report
- November 2023
- 150 Pages
Global
From €2880EUR$3,250USD£2,480GBP
€4298EUR$4,850USD£3,701GBP
- Report
- August 2022
Global
From €3988EUR$4,500USD£3,434GBP
- Report
- June 2024
- 200 Pages
Global
From €7045EUR$7,950USD£6,067GBP
- Report
- February 2024
- 288 Pages
Global
From €7045EUR$7,950USD£6,067GBP
- Report
- January 2022
- 60 Pages
Global
From €3500EUR$3,950USD£3,014GBP
- Report
- May 2024
- 180 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- September 2022
- 114 Pages
Global
From €3390EUR$3,825USD£2,919GBP
€3988EUR$4,500USD£3,434GBP
- Report
- October 2021
- 110 Pages
United States
From €3323EUR$3,750USD£2,862GBP

The Coagulation Factor market is a segment of the Hematological Drugs market, which includes drugs used to treat blood-related disorders. Coagulation Factors are proteins that help the body form blood clots, and are used to treat conditions such as hemophilia, von Willebrand disease, and other bleeding disorders. These drugs are typically administered intravenously, and are often used in combination with other treatments.
The Coagulation Factor market is highly competitive, with a number of companies offering products for the treatment of bleeding disorders. Some of the major players in the market include Pfizer, Novo Nordisk, Bayer, CSL Behring, and Shire. Show Less Read more